Simplifying procedure for prediction of resistance risk in CML patients - Test of sensitivity to TKI ex vivo. [electronic resource]
Producer: 20170109Description: 67-75 p. digitalISSN:- 1096-0961
- Antineoplastic Agents -- pharmacology
- Cell Death -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dasatinib -- pharmacology
- Drug Resistance, Neoplasm
- Humans
- Imatinib Mesylate -- pharmacology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Leukocytes -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- Pyrimidines -- pharmacology
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.